Quaker Chemical Corporation (NYSE:KWR) acquired Ikv Tribologie Ikvt for ?32.2 million during February 2024. Quaker acquired Ikv for ?32.2 million, including an initial cash payment of ?27.6 million, subject to routine and customary post-closing adjustments related to working capital and net indebtedness levels as well as earn-out provisions related to the finalization of 2023 earnings currently estimated at ?4.6 million. Acquisition included approximately $4.8 million (?4.44 million) of cash and cash equivalents. IKVT will be part of the Quaker?s EMEA segment. SG Corporate & Investment Banking acted as financial advisor to I.k.v. Tribologie - Ikvt.

Quaker Chemical Corporation (NYSE:KWR) completed the acquisition of Ikv Tribologie Ikvt during February 2024.